FourThought Financial Partners, LLC
Source: SEC Form 13F · as of Mar 2026FourThought Financial Partners, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $66.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$66.1M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 79,487 | $15.7M |
| ABTABBOTT LABORATORIES | 128,814 | $13.2M |
| AMGNAMGEN INC | 32,203 | $11.3M |
| LLYELI LILLY & Co | 5,576 | $5.1M |
| JNJJOHNSON & JOHNSON | 15,028 | $3.7M |
| ABBVAbbVie Inc. | 16,628 | $3.6M |
| ZTSZoetis Inc. | 30,298 | $3.6M |
| NVONovo Nordisk A/S | 93,399 | $3.4M |
| MCKMcKesson Corporation | 1,799 | $1.6M |
| PMPhilip Morris International Inc | 6,643 | $1.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,440 | $660K |
| MRKMerck & Co., Inc. | 5,057 | $608K |
| PFEPFIZER INC | 17,309 | $486K |
| CORTCORCEPT THERAPEUTICS INC | 11,720 | $472K |
| BMYBRISTOL MYERS SQUIBB CO | 7,199 | $437K |
| INCYIncyte Corp. | 3,563 | $335K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 710 | $317K |
| GILDGILEAD SCIENCES, INC. | 1,858 | $259K |
| ALKSAlkermes plc. | 6,068 | $215K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.